Skip to main content
. 2018 Jul 17;92(15):e00246-18. doi: 10.1128/JVI.00246-18

TABLE 1.

oHSV replication in GSC and ScGC lines

Tumor type and patient specimen Virus Titer ratioa in:
GSCs ScGCs
Primary
    MGG4 G207 0.7 9.7
FΔ6 13.7 136.6
G47Δ 32.7 415.7
    MGG8 G207 0.5 63.2
FΔ6 154.9 34.5
G47Δ 42.3 327.6
    MGG18 G207 3.5
FΔ6 NT NT
G47Δ 343
    MGG29 G207 1.3 83.3
FΔ6 25.8 83.3
G47Δ 21.4 68.5
    MGG75 G207 0.5 8.2
FΔ6 6.3 27.3
G47Δ NT NT
Recurrent
    MGG31 G207 0.97 69.7
FΔ6 N/T 612
G47Δ 192 207
    MGG70R G207 0.4
FΔ6 29.7 None
G47Δ 8.1
    MGG70RRb G207 0.7
FΔ6 39.2 None
G47Δ 7.0
    MGG123 G207 0.7 99
FΔ6 198.5 NT
G47Δ 20.7 614
a

The titer at 24 hpi was divided by the titer measured at 5 to 8 hpi. Cells were considered permissive if the ratio was at least 5 or represented half a log increase from the value at eclipse. Values were calculated from single experiments with technical triplicates. None, cells do not exist; NT, not tested.

b

MGG70RR was a re-recurrent tumor from MGG70R.

HHS Vulnerability Disclosure